Gland Pharma Limited has informed the Exchange about Schedule of meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has informed the stock exchanges about an upcoming one-on-one meeting with UTI Mutual Fund scheduled for June 6, 2025. This is a routine disclosure made under SEBI's listing regulations to keep the market informed about investor engagements. The company has noted that the schedule may change due to unforeseen circumstances on either side. No business or financial details were shared in this filing.
This is a routine regulatory disclosure with no direct impact on stock price or shareholder value. Such meetings are part of normal investor relations activity and signal ongoing engagement with institutional investors.